Skip to main content
Premium Trial:

Request an Annual Quote

Jury Awards Promega $52M in Damages in IP Suit with Life Tech


Promega said this week that a jury has ruled in its favor in a patent infringement suit against Life Technologies and awarded it $52 million in damages.

The United States District Court for the Western District of Wisconsin found that Life Tech willfully infringed Promega's patents related to short tandem repeats.

The willfulness verdict means that the court may increase the final damage amount, Promega said.

The company noted that the court has also set a schedule to consider an injunction against Life Technologies for its sale of the infringing products, but did not provide further details.

Promega filed its lawsuit against Life Tech in May 2010. The court issued a summary judgment in November that found Life Tech to be directly infringing Promega's patents with the sale of its own STR kits.

The technology is used for genetic analysis applications including genetic research, cell line authentication, bone marrow transplantation monitoring, forensic training, and cancer analysis.

"Life Technologies is considering its options in light of the verdict … including post-trial motions and appeals," Life Tech said in a statement.

The company added that sales of its STR products for the core forensics and paternity fields are not affected by the verdict.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.